Dr. Lise Alschuler to Tour United States and Present: Practitioner-exclusive event; continuing education credits applied for! GREEN BAY, WI (February 11, 2013) Integrative Therapeutics is pleased to announce the addition of Lise Alschuler, N.D. to their Medical...
Clinical Pearls Sussanna Czeranko, ND, BBE The longer you take this bath, the happier you feel. The feeling you get is angelic. I cannot explain it. -Benedict...
Open Pilot Study Using a Liquid Emulsion Form of Cetyl Myristoleate David Arneson, NMD Seth Black, NMD Barry Gelinas, MD Jeffrey Langland, PhD Robert Waters, PhD The objective of this open uncontrolled study was to evaluate the benefit of a novel liquid emulsion form...
Sussanna Czeranko, ND, BBE The Allopaths have endeavored to cure sick humanity on the basis of the highly erroneous idea that man can change the laws of nature that govern our being, and cure the cause of disease by simply ignoring it. To cure disease by poisoning its...
David Schleich, PhD Part One Numerous teachers and scholars in the medical education field believe that their biggest job is to help our interns learn how to integrate communication and clinical reasoning (Mead and Bower). The elements of our curricula, they believe,...
David M. Brady, ND, DC, CCN, DACBN Part Five in the Clinical Rounds series. These clinical rounds are real case studies from my practice. It is my aim to present interesting cases to facilitate thought and discussion about novel diagnostic and therapeutic techniques...
Palliative care is not about abandoning treatment or losing hope—it is about adding another layer of support. This article explores an integrative, interdisciplinary approach that introduces symptom management, quality-of-life support, advance care planning, and emotional and spiritual care early in the course of serious illness.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Approximately 1 in 10 fathers experience a perinatal mood or anxiety disorder, yet paternal PMADs remain frequently overlooked. This review explores the hormonal and psychosocial changes accompanying fatherhood and their implications for recognizing, screening, and supporting paternal mental health.
Can curcumin and artesunate play a role in integrative prostate cancer care? This two-patient case series examines PSA trajectories and pathology during an oral botanical protocol incorporating curcumin and artesunate, while highlighting potential mechanisms, iron-related adverse effects, and the need for further clinical investigation.
Suzetrigine introduces a novel mechanism for treating moderate to severe acute pain by selectively inhibiting NaV1.8 channels on peripheral nociceptors. This review examines its mechanism, clinical efficacy, safety, and potential role within multimodal naturopathic and integrative pain management.
Active surveillance does not have to mean simply “watching and waiting.” This case follows a man with localized intermediate-risk prostate cancer over approximately 20 months, integrating conventional oncologic monitoring with serial assessment and individualized management of metabolic health, inflammation, gastrointestinal dysbiosis, environmental exposures, nutrition, and lifestyle.
The 2026 American Association of Naturopathic Physicians (AANP) Convention arrived in Madison, Wisconsin, under unusual skies. Wildfire smoke had drifted across the region, leaving the city enveloped in smoke and fog as naturopathic physicians, students, educators,...
Daraxonrasib is reshaping the therapeutic landscape of RAS-driven pancreatic cancer and raising new considerations for integrative clinicians. This article explores pan-RAS inhibition alongside practical strategies for nutrition, exercise, symptom management, and careful evaluation of botanical and nutrient interactions within a precision integrative oncology framework.
This case follows a 44-year-old woman with inflammatory breast cancer that progressed to osseous metastatic disease and was managed through a multimodal naturopathic, immune-directed, and conventional oncology strategy. Serial imaging and molecular surveillance ultimately demonstrated complete metabolic response, zero circulating tumor cells, and repeatedly undetectable ctDNA, highlighting the potential value of adaptive, interdisciplinary integrative oncology care.